DK1537122T3 - Antidepressive indolalkylderivater af heterocyclus-kondenserede benzodioxanmathylaminer - Google Patents

Antidepressive indolalkylderivater af heterocyclus-kondenserede benzodioxanmathylaminer

Info

Publication number
DK1537122T3
DK1537122T3 DK03754498T DK03754498T DK1537122T3 DK 1537122 T3 DK1537122 T3 DK 1537122T3 DK 03754498 T DK03754498 T DK 03754498T DK 03754498 T DK03754498 T DK 03754498T DK 1537122 T3 DK1537122 T3 DK 1537122T3
Authority
DK
Denmark
Prior art keywords
disorder
methylamines
benzodioxane
antidepressant
heterocycle
Prior art date
Application number
DK03754498T
Other languages
English (en)
Inventor
Gary Paul Stack
Michael Byron Webb
Deborah Ann Evrard
Dahui Zhou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1537122T3 publication Critical patent/DK1537122T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
DK03754498T 2002-09-12 2003-09-11 Antidepressive indolalkylderivater af heterocyclus-kondenserede benzodioxanmathylaminer DK1537122T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41034702P 2002-09-12 2002-09-12
US10/659,238 US6800637B2 (en) 2002-09-12 2003-09-10 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
PCT/US2003/028524 WO2004024734A1 (en) 2002-09-12 2003-09-11 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines

Publications (1)

Publication Number Publication Date
DK1537122T3 true DK1537122T3 (da) 2007-12-27

Family

ID=32717176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03754498T DK1537122T3 (da) 2002-09-12 2003-09-11 Antidepressive indolalkylderivater af heterocyclus-kondenserede benzodioxanmathylaminer

Country Status (17)

Country Link
US (1) US6800637B2 (da)
EP (1) EP1537122B9 (da)
JP (1) JP2006510595A (da)
KR (1) KR20050042176A (da)
CN (1) CN100358898C (da)
AT (1) ATE370953T1 (da)
AU (1) AU2003272322A1 (da)
BR (1) BR0314513A (da)
CA (1) CA2497214A1 (da)
DE (1) DE60315843T2 (da)
DK (1) DK1537122T3 (da)
EC (1) ECSP055660A (da)
ES (1) ES2291673T3 (da)
MX (1) MXPA05002840A (da)
NO (1) NO20051768D0 (da)
RU (1) RU2005107587A (da)
WO (1) WO2004024734A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089053A2 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US20080139546A1 (en) * 2006-09-29 2008-06-12 Wyeth Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines
WO2008118935A1 (en) * 2007-03-26 2008-10-02 Neurogen Corporation Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
AR066760A1 (es) * 2007-05-30 2009-09-09 Wyeth Corp Derivados heteroarilo de benzodioxanos heterociclo-fusionados antidepresivos, composiciones farmaceuticas, procesos de obtencion
JP2012528120A (ja) * 2009-05-27 2012-11-12 ユニヴェルシテ リブル ドゥ ブリュッセル ミエロペルオキシダーゼ阻害3−アルキル−5−フルオロインドール誘導体
EP2459533A4 (en) 2009-07-30 2013-01-16 Univ Singapore SMALL MOLECULE INHIBITORS OF ISOPRENYLCYSTEIN CARBOXYL METHYLTRANERASE WITH POTENTIAL ANTICANCING ACTIVITY
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
EP2481740B1 (en) * 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043709C (en) 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
US5869490A (en) * 1996-10-15 1999-02-09 American Home Products Corporation Azaheterocyclymethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino (2,3-e) indol-8-one
GB9704948D0 (en) * 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
DE19858340A1 (de) 1998-12-17 2000-06-21 Merck Patent Gmbh Verfahren zur Herstellung von 3-Alkanoyl- und 3-Alkylindolen
US6458802B1 (en) * 2001-03-14 2002-10-01 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline
US6800648B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
EP1392700B1 (en) * 2001-04-30 2004-09-29 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene
AU2002309769B2 (en) * 2001-05-17 2008-04-17 Wyeth Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline

Also Published As

Publication number Publication date
AU2003272322A1 (en) 2004-04-30
CN100358898C (zh) 2008-01-02
DE60315843D1 (de) 2007-10-04
ATE370953T1 (de) 2007-09-15
RU2005107587A (ru) 2006-01-20
US20040138222A1 (en) 2004-07-15
CA2497214A1 (en) 2004-03-25
MXPA05002840A (es) 2005-08-16
NO20051768L (no) 2005-04-11
EP1537122B9 (en) 2007-10-31
JP2006510595A (ja) 2006-03-30
EP1537122B1 (en) 2007-08-22
ES2291673T3 (es) 2008-03-01
DE60315843T2 (de) 2008-05-15
KR20050042176A (ko) 2005-05-04
EP1537122A1 (en) 2005-06-08
BR0314513A (pt) 2005-08-09
CN1701075A (zh) 2005-11-23
ECSP055660A (es) 2005-07-06
WO2004024734A1 (en) 2004-03-25
US6800637B2 (en) 2004-10-05
NO20051768D0 (no) 2005-04-11

Similar Documents

Publication Publication Date Title
NO20051768D0 (no) Antidepressive indolalkylderivater av heterocykliske, kondenserte benzodioksanmetylaminer
NO20051769L (no) Antidepressivt virkende azaheterocykylmetylderivater av heterocykluskondenserte benzodioksaner
ECSP055659A (es) Derivados de cicloalquilamina antidepresiva de benzodioxanos fusionados con heterociclos
DE60201829D1 (de) Azaheterocyclylmethyl derivative des 2,3-dihydro-1,4-dioxino(2,3-f)quinolins als antidepressiva
CO6220910A2 (es) Proceso para la producir compuestos pesticidas de benzamidas
BRPI0516735A (pt) esquema de sìntese melhorada para lacosamida
NO20055208L (no) 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer
EA200600049A1 (ru) Способы получения 3 - бензазепинов
EA200701588A1 (ru) Способы получения замещённых фенилпиразолмочевин
DK1720823T3 (da) Ny fremgangsmåde til syntese af substituerede alpha-amino-indanderivater
BR0314277A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
DE502004011239D1 (de) Verfahren zur dehydratisierung substituierter 4-dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-katalyse
NO20076344L (no) Piperazin-piperidin-antagonister og agonister av 5-HT1A-reseptoren
NO20051617L (no) Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet
AR035083A1 (es) Derivados azaheterociclilmetilicos de 7,8-dihidro-6h-5-oxa-1-aza-fenantreno, composiciones farmaceuticas, el uso de dichos derivados para la preparacion de un medicamento antidepresivo e intermediarios
WO2002088136A3 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
ECSP088360A (es) Métodos para preparar derivados de ácido glutámico
ATE402136T1 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
CR7723A (es) Derivados de azaheterociclilmetilo de benzodioxanos fusionados con heterociclos antidepresivos
BRPI0514313A (pt) processo para sintetizar um composto, e, composto
AR048134A1 (es) La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
TH127131B (th) กระบวนการเตรียมสารประกอบที่มีความว่องไวต่อปฏิกิริยาทางแสงโดยใช้ การไฮโดรจีเนชันแบบถ่ายเท
ECSP066998A (es) Derivados quirales de heptina para la preparación de epotilonas y procesos para prepararlos
AR039723A1 (es) Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina